# Improving Sexual Dysfunction with Cinnamon Leaf Extract and Nanoemulsion by Using a Rat Model

**Authors:** Yi-No Wu, Jin-Wei Lee, Han-Sun Chiang, Baskaran Stephen Inbaraj, Wen-Jhen Chen, Bing-Huei Chen

PMC · DOI: 10.3390/ph19020284 · Pharmaceuticals · 2026-02-07

## TL;DR

This study shows that a nanoemulsion made from cinnamon leaf extract improves sexual dysfunction in rats more effectively than the extract alone.

## Contribution

The novel contribution is the development and evaluation of a cinnamon leaf nanoemulsion for treating sexual dysfunction in a rat model.

## Key findings

- CLEN improved sexual behavior and erectile response more than CLE in rats.
- CLEN enhanced neurovascular function and reduced fibrosis in penile tissue.
- CLEN increased NO and cGMP levels while reducing PDE5, suggesting modulation of the NO-cGMP pathway.

## Abstract

Background/Objectives: Taiwan cinnamon leaves have been reported to be effective in improving chronic diseases. Herein, cinnamon leaf extract (CLE) and nanoemulsion (CLEN) were prepared to explore their effects in improving sexual dysfunction in rats. Methods: Following extraction with 80% ethanol and analysis by UPLC-MS/MS, CLEN was prepared using an optimal ratio of soybean oil, lecithin, Tween 80, deionized water, and CLE. A total of 48 male rats and 48 female rats were used, with the former being induced with erectile dysfunction, followed by treatment with CLEN or CLE at two doses (100 mg/kg and 50 mg/kg) for 4 weeks. After conducting the penile reflex test, male rats were paired with female rats for measurement of sexual behavior and ICP/MAP. Following sacrifice, α-SMA, nNOS, and β-III tubulin expression areas were measured by histochemical analyses; SMC/collagen ratio by Masson’s trichrome staining; and NO, cGMP, and PDE5 levels by ELISA kits. Results: CLEN was more effective than CLE in increasing intromission frequency, decreasing intromission and ejaculation latency, and recovering erectile response for improving copulatory and ejaculatory performances. A higher maximum ICP/MAP ratio was shown for CLEN through elevation of neurovascular function and erectile capacity. Additionally, CLEN efficiently reduced fibrosis, enhanced neuronal marker expression, and increased the SMC/collagen ratio, leading to penile tissue protection and neural regeneration. Both treatments showed elevated levels of NO and cGMP with a reduction in PDE5, probably through modulation of the NO-cGMP signaling pathway. Conclusions: CLEN was more effective than CLE in restoring erectile function in rats. Some more clinical trials are needed to verify this finding.

## Linked entities

- **Proteins:** ACTA1 (actin alpha 1, skeletal muscle), NOS1 (nitric oxide synthase 1), Nos1 (nitric oxide synthase 1, neuronal), Pkg21D (Protein kinase, cGMP-dependent at 21D), PDE5A (phosphodiesterase 5A)
- **Chemicals:** lecithin (PubChem CID 10425706), Tween 80 (PubChem CID 443315), deionized water (PubChem CID 962), 80% ethanol (PubChem CID 702)
- **Diseases:** erectile dysfunction (MONDO:0005362), sexual dysfunction (MONDO:0002134)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Actg2 (actin gamma 2, smooth muscle) [NCBI Gene 25365] {aka ACTGE, SMGA}, Rho (rhodopsin) [NCBI Gene 24717], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Rhoa (ras homolog family member A) [NCBI Gene 117273] {aka Arha, Arha2}, Kdr (kinase insert domain receptor) [NCBI Gene 25589] {aka Vegfr-2}, Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, Nos1 (nitric oxide synthase 1) [NCBI Gene 24598] {aka bNOS}, Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}
- **Diseases:** male infertility (MESH:D007248), neurological disorder (MESH:D009461), hypogonadism (MESH:D007006), osteoarthritis (MESH:D010003), hypoxia (MESH:D000860), obesity (MESH:D009765), paralysis (MESH:D010243), weakness (MESH:D018908), Sexual Dysfunction (MESH:D012735), diabetes (MESH:D003920), cancer (MESH:D009369), adenocarcinoma (MESH:D000230), drug abuse (MESH:D019966), Alzheimer's disease (MESH:D000544), cavernous (MESH:D020786), anxiety (MESH:D001007), atrophy (MESH:D001284), testicular toxicity (MESH:D013733), loss (MESH:D016388), fibrosis (MESH:D005355), hyperglycemia (MESH:D006943), injury (MESH:D014947), inflammation (MESH:D007249), headache (MESH:D006261), Parkinson's disease (MESH:D010300), compression (MESH:D009408), disturbances (MESH:D014832), pain (MESH:D010146), visual disturbances (MESH:D014786), ejaculation (MESH:D061686), indigestion (MESH:D004415), chronic diseases (MESH:D002908), endothelial (MESH:D005642), corpus cavernosum (MESH:D061085), spinal nerve injury (MESH:D061227), kidney disease (MESH:D007674), depression (MESH:D003866), type II diabetic (MESH:D003924), HE (MESH:D008228), type I diabetes (MESH:D003922), dementia (MESH:D003704), impaired sexual function and (MESH:D012734), cardiovascular disease (MESH:D002318), hypoactive sexual desire disorder (MESH:D020018), prostatic hyperplasia (MESH:D011470), osteoporosis (MESH:D010024), insulin resistance (MESH:D007333), ED (MESH:D007172), dizziness (MESH:D004244), weight loss (MESH:D015431), cytotoxicity (MESH:D064420), neurotransmission abnormalities (MESH:D000014), cavernous nerve damage (MESH:D000080902), carcinogenic compound (MESH:D005597), hypertension (MESH:D006973), crush injury (MESH:D000071576)
- **Chemicals:** acetic (MESH:D019342), Progesterone (MESH:D011374), copper (MESH:D003300), HCl (MESH:D006851), NaOH (MESH:D012972), ethanol (MESH:D000431), nitric oxide (MESH:D009569), cholesterol (MESH:D002784), polyethylene (MESH:D020959), linolenic acid (MESH:D017962), kaempferol (MESH:C006552), EPA (MESH:D015118), Water (MESH:D014867), quercetin-3-O-galactoside (MESH:C021304), essential oil (MESH:D009822), acetylcholine (MESH:D000109), coumarin (MESH:C030123), cinnamic acid (MESH:C029010), bisphenol A (MESH:C006780), CA (MESH:C012843), testosterone (MESH:D013739), acetyl-CoA (MESH:D000105), arachidonic acid (MESH:D016718), rompun (MESH:D014991), choline (MESH:D002794), uric acid (MESH:D014527), potassium dihydrogen phosphate (MESH:C013216), quercetin (MESH:D011794), MDA (MESH:D015104), vardenafil (MESH:D000069058), xylene (MESH:D014992), benzoic acid (MESH:D019817), omega-3 fatty acid (MESH:D015525), paroxetine (MESH:D017374), carbon (MESH:D002244), rutin (MESH:D012431), acetonitrile (MESH:C032159), essential fatty acids (MESH:D005228), triglyceride (MESH:D014280), Span-80 (MESH:C018665), linoleic acid (MESH:D019787), methanol (MESH:D000432), saline (MESH:D012965), GTP (MESH:D006160), ginsenosides (MESH:D036145), cGMP (MESH:D006152), bisphenol F (MESH:C000611646), n-hexane (MESH:C026385), maltodextrin (MESH:C008315), caffeic acid (MESH:C040048), alcohol (MESH:D000438), heparin (MESH:D006493), isorhamnetin (MESH:C047368), tadalafil (MESH:D000068581), Potassium chloride (MESH:D011189), Texas Red (MESH:C034657), Tween 80 (MESH:D011136), dopamine (MESH:D004298), ROS (MESH:D017382), calcium (MESH:D002118)
- **Species:** Cinnamomum verum (Ceylon cinnamon, species) [taxon 128608], Mus musculus (house mouse, species) [taxon 10090], Cinnamomum burmanni (Batavia cinnamon, species) [taxon 119261], Epimedium brevicornu (species) [taxon 253618], Allium tuberosum (species) [taxon 4683], Cinnamomum aromaticum (species) [taxon 119260], Codonopsis pilosula (species) [taxon 86864], Cinnamomum loureiroi (Saigon cinnamon, species) [taxon 688535], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Cassia (genus) [taxon 53851], Cinnamomum osmophloeum (species) [taxon 258907]
- **Cell lines:** HE — Trichoplusia ni (Cabbage looper), Spontaneously immortalized cell line (CVCL_C190)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944667/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944667/full.md

## References

85 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944667/full.md

---
Source: https://tomesphere.com/paper/PMC12944667